|
|
| Research article summary (published 4 Mar 2008): |
Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system.
Full Abstract
This paper considers the suitability of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) as the gold standard in registration trials of treatments for Alzheimer's disease. Working groups have recommended replacing the ADAS-cog if suitable automated alternatives can be found. This paper makes the case for the Cognitive Drug Research (CDR) computerised cognitive assessment system, as an example of a suitable instrument to replace the ADAS-cog. The CDR system has been widely used in dementia work for 20 years and shows good correlations to the ADAS-cog, while additionally assessing the domains of attention, working memory, information processing and retrieval speed of information held in memory. The utility of the system in evaluating and differentiating the major dementias will be described, as well as its ability to track deterioration over time. Its validation as a core measure of cognitive dysfunction in the dementias will be described, as will work showing that various CDR measures relate closely to activities of daily living. The sensitivity of the CDR system to anticholinesterases will be described in Alzheimer's disease, dementia with Lewy bodies and Parkinson's dementia. Finally, the CDR system has a large normative database which allows treatment effects in dementia to be put into an unambiguous clinical perspective.2008 S. Karger AG, Basel
Learn Faster Today Improve your study skills
Author information
Author/s: Wesnes, Keith A (KA);
Affiliation: Cognitive Drug Research Ltd., Goring-on-Thames, UK. keithw@cognitivedrugresearch.com
Journal and publication information
Publication Type: Journal Article; Review
Journal: Neuro-degenerative diseases (Neurodegener Dis), published in Switzerland. (Language: eng)
Reference: 2008-; vol 5 (issue 3-4) : pp 261-3
Dates: Created 2008/03/06; Completed 2008/05/15;
PMID: 18322407, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- A neuropsychological test battery for use in Alzheimer disease clinical trials.
30 Aug 2007 - Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
10 Jun 2007 - The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
29 Apr 2006 - Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
30 May 2007 - Target symptoms and outcome measures: cognition.
27 Feb 2007 - [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project]
29 Sep 2007 - [Vascular factors and progression of cognitive decline in elderly people]
30 Aug 2005 - Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
20 Sep 2006 - Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.
16 Feb 2008 - Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
30 Aug 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.